Hematology/Oncology

• ATA issues guidelines for anaplastic thyroid cancer management

• Endocrine Today, December 2012
• The American Thyroid Association has released the first set of comprehensive guidelines for the management of anaplastic thyroid cancer, a rare but lethal...More »

• In the Journals

• Robotic surgery shows promise for removal of voice box tumors

• HemOnc Today, December 25, 2012
• Transoral robotic surgery through the mouth is a safe and effective procedure for patients with head and neck cancers, according to results of a...More »

• Meeting News Coverage

• Doxepin rinse significantly reduced oral mucositis pain

• HemOnc Today, November 25, 2012
• The tricyclic antidepressant doxepin reduces oral mucositis when used as a mouth rinse, according to findings of a randomized study presented at the 2012...More »

• Imaging Analysis

• Nasopharyngeal carcinoma in an HIV-positive patient with cranial nerve defects

• HemOnc Today, November 25, 2012
  Daniel E. Meltzer, MD; Esha Gollapalle, MD; Grigorios Chrysofakis , MD; Ippolito Modica, MD; Michael Chung, MD; Munir Ghesani, MD
• A 48-year-old black man with a history of chronic hepatitis C and HIV, well controlled on highly active antiretroviral therapy, presented with a 3-month...More »

• Imaging Analysis

• Nasopharyngeal carcinoma in an HIV-positive patient with cranial nerve defects

• Infectious Disease News, December 2012
  Daniel E. Meltzer, MD; Esha Gollapalle, MD; Grigorios Chrysofakis , MD; Ippolito Modica, MD; Michael Chung, MD; Munir Ghesani, MD
• A 48-year-old black man with a history of chronic hepatitis C and HIV, well controlled on highly active antiretroviral therapy, presented with a 3-month...More »

• In the Journals Perspective

• Cetuximab conferred benefits regardless of tumor HPV status

• HemOnc Today, November 25, 2012
• Among patients with recurrent or metastatic squamous cell carcinoma of the head and neck, the survival benefits conferred by the addition of cetuximab to...More »

• In the Journals Perspective

• Cetuximab conferred benefits regardless of tumor HPV status

• Infectious Disease News, December 2012
• Among patients with recurrent or metastatic squamous cell carcinoma of the head and neck, the survival benefits conferred by the addition of cetuximab to...More »

• In the Journals

• HPV DNA alone poor biomarker for HPV-driven oropharyngeal cancers

• HemOnc Today, October 25, 2012
• Data from two recent studies of head and neck cancers associated with HPV indicated that HPV DNA alone was an insufficient diagnostic tool and prognostic...More »

• Meeting News Coverage Perspective

• Chemoradiotherapy superior to panitumumab-radiotherapy combination

• HemOnc Today, November 10, 2012
• Chemoradiotherapy conferred better locoregional control rates than panitumumab plus radiotherapy in a cohort of patients with locally advanced squamous...More »

• In the Journals

• HPV vaccine linked to syncope, skin infections post-vaccination

• October 2, 2012
• The quadrivalent human papillomavirus vaccine was associated with same-day syncope and skin infections in the 2 weeks after vaccination, according to a...More »

Personalize your page!

Register for Healio to get content tailored to your specialty and areas of interest. It’s FREE and only takes one minute. Register now!